HLA-G 14-bp insertion/deletion polymorphism is a risk factor for HTLV-1 infection

AIDS Research and Human Retroviruses

Volumn 27, Issue 3, 2011, Pages 283-288

  Haddad, Rodrigo ^a   Cilião Alves, Daiani Cristina ^a   Rocha Junior, Maurício Cristiano ^a   Azevedo, Rochele ^a   Do Socorro Pombo De Oliveira, Maria ^b   Takayanagui, Oswaldo Massaiti ^a   Donadi, Eduardo Antônio ^a   Covas, Dimas Tadeu ^a   Kashima, Simone ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; T CELL LEUKEMIA; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; DELTARETROVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; DNA, VIRAL; FEMALE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; VIRAL LOAD;

EID: 79952578908     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0165     Document Type: Article

References (39)

1. Carosella ED, Moreau P, Le MJ, et al.: HLA-G molecules: From maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003;81:199-252. (Pubitemid 38009044)
2. Ellis SA, Sargent IL, Redman CW, and McMichael AJ. Evi-dence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986;59:595-601. (Pubitemid 17178284)
3. Geraghty DE, Koller BH, and Orr HT. A human major his-tocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987;84:9145-9149.
4. Kovats S, Main EK, Librach C, et al.: A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248: 220-223. (Pubitemid 120031455)
5. McMaster MT, Librach CL, Zhou Y, et al.: Human placental HLA-G expression is restricted to differentiated cyto-trophoblasts. J Immunol 1995;154:3771-3778.
6. Fuzzi B, Rizzo R, Criscuoli L, et al.: HLA-G expression in early embryos is a fundamental prerequisite for the obtain-ment of pregnancy. Eur J Immunol 2002;32:311-315. (Pubitemid 34173321)
7. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, and Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94: 11520-11525. (Pubitemid 27451031)
8. Cordero EA, Veit TD, da Silva MA, et al.: HLA-G poly-morphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009;74:308-313.
9. Tripathi P, Abbas A, Naik S, and Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of preg-nancy. Tissue Antigens 2004;64:706-710. (Pubitemid 39628052)
10. Hviid TV, Hylenius S, Rorbye C, and Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Im-munogenetics 2003;55:63-79. (Pubitemid 36702743)
11. Rousseau P, Le DM, Mouillot G, et al.: The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003;64:1005-1010. (Pubitemid 37413707)
12. Hiby SE, King A, Sharkey A, and Loke YW. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tis-sue Antigens 1999;53:1-13. (Pubitemid 29084169)
13. Ratner L. Adult T cell leukemia lymphoma. Front Biosci 2004;9:2852-2859.
14. Nagai M and Osame M. Human T-cell lymphotropic virus type I and neurological diseases. J Neurovirol 2003;9: 228-235. (Pubitemid 36656456)
15. Gessain A, Barin F, Vernant JC, et al.: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410. (Pubitemid 15231248)
16. La GL. HTLV-I-associated infective dermatitis: Past, present, and future. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: S46-S49.
17. Mariette X, Agbalika F, Zucker-Franklin D, et al.: Detection of the tax gene of HTLV-I in labial salivary glands from patients with Sjogren's syndrome and other diseases of the oral cavity. Clin Exp Rheumatol 2000;18:341-347 (Pubitemid 30409103)
18. Mochizuki M, Ono A, Ikeda E, et al.: HTLV-I uveitis. J Ac-quir Immune Defic Syndr Hum Retrovirol 1996;13:S50-S56.
19. Morgan OS, Rodgers-Johnson P, Mora C, and Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989;2: 1184-1187.
20. Nishioka K, Maruyama I, Sato K, et al.: Chronic inflamma-tory arthropathy associated with HTLV-I. Lancet 1989;1:441. (Pubitemid 19059182)
21. Osame M, Usuku K, Izumo S, et al.: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;1:1031-1032. (Pubitemid 16102987)
22. Cooper SA, van der Loeff MS, and Taylor GP. The neurology of HTLV-1 infection. Pract Neurol 2009;9:16-26.
23. Verdonck K, Gonzalez E, Van DS, et al.: Human T-lym-photropic virus 1: Recent knowledge about an ancient in-fection. Lancet Infect Dis 2007;7:266-281. (Pubitemid 46414075)
24. Asquith B and Bangham CR. Quantifying HTLV-I dynamics. Immunol Cell Biol 2007;85:280-286. (Pubitemid 46878928)
25. Nagai M, Usuku K, Matsumoto W, et al.: Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymp-tomatic HTLV-I carriers: High proviral load strongly pre-disposes to HAM/TSP. J Neurovirol 1998;4:586-593. (Pubitemid 29042065)
26. Asquith B, Mosley AJ, Barfield A, et al.: A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 2005;86:1515-1523. (Pubitemid 40613271)
27. Komatsu F and Yoshida S. Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells. Oncol Res 1999;11:213-218.
28. Hviid TV, Hylenius S, Hoegh AM, Kruse C, and Christiansen OB. HLA-G polymorphisms in couples with recurrent spon-taneous abortions. Tissue Antigens 2002;60:122-132. (Pubitemid 35305618)
29. Miley WJ, Suryanarayana K, Manns A, et al.: Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses 2000;16:665-675. (Pubitemid 30235992)
30. Raymond M and Rousset F. Genepop (Version-1.2). Popu-lation-Genetics Software for Exact Tests and Ecumenicism. J Hered 1995;86:248-249.
31. Carosella ED, Moreau P, Lemaoult J, and Rouas-Freiss N. HLA-G: From biology to clinical benefits. Trends Immunol 2008;29:125-132.
32. Caumartin J, Favier B, Daouya M, et al.: Trogocytosis-based generation of suppressive NK cells. EMBO J 2007;26: 1423-1433. (Pubitemid 46398697)
33. Lemaoult J, Caumartin J, Daouya M, et al.: Immune regulation by pretenders: Cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007;109:2040-2048. (Pubitemid 46348204)
34. Rouas-Freiss N Moreau P, Ferrone S, and Carosella ED. HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism? Cancer Res 2005;65:10139-10144. (Pubitemid 41743699)
35. Fabris A, Catamo E, Segat L, et al.: Association between HLA-G 3 ' UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS 2009;23:177-182.
36. Lajoie J, Massinga LM, Poudrier J, et al.: Blood soluble hu-man leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese com-mercial sex workers. Hum Immunol 2010;71:182-185.
37. Segat L, Catamo E, Fabris A, et al.: HLA-G 3' UTR haplo-types and HIV vertical transmission. AIDS 2009;23:1916-1918.
38. Martinetti M, Pacati I, Cuccia M, et al.: Hierarchy of baby-linked immunogenetic risk factors in the vertical transmis-sion of hepatitis C virus. Int J Immunopathol Pharmacol 2006;19:369-378. (Pubitemid 44181959)
39. Zheng XQ, Zhu F, Shi WW, Lin A, and Yan WH. The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infec-tion in children. Tissue Antigens 2009;74:317-321.